avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfdp1
|
ENSMUSG00000038482.10 | transcription factor Dp 1 |
Wt1
|
ENSMUSG00000016458.7 | Wilms tumor 1 homolog |
Egr2
|
ENSMUSG00000037868.9 | early growth response 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfdp1 | mm10_v2_chr8_+_13339656_13339674 | 0.89 | 5.3e-13 | Click! |
Wt1 | mm10_v2_chr2_+_105126505_105126529 | 0.76 | 9.7e-08 | Click! |
Egr2 | mm10_v2_chr10_+_67535493_67535583 | 0.56 | 3.6e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_142657466 | 42.78 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr7_-_142659482 | 32.37 |
ENSMUST00000121128.1
|
Igf2
|
insulin-like growth factor 2 |
chr11_-_12037391 | 26.07 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr12_-_76709997 | 25.63 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chr2_-_156839790 | 24.85 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr7_-_143460989 | 24.44 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr11_+_95010277 | 22.87 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr7_-_38107490 | 21.58 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr8_+_22974844 | 20.63 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr12_+_109453455 | 20.18 |
ENSMUST00000109844.4
ENSMUST00000109842.2 ENSMUST00000109843.1 ENSMUST00000109846.4 ENSMUST00000173539.1 ENSMUST00000109841.2 |
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr9_+_65101453 | 19.99 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chrX_-_73659724 | 19.33 |
ENSMUST00000114473.1
ENSMUST00000002087.7 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr4_-_3938354 | 19.06 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr19_-_24555819 | 18.60 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
Pip5k1b
|
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
chr2_+_163054682 | 18.20 |
ENSMUST00000018005.3
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr14_-_79301623 | 18.09 |
ENSMUST00000022595.7
|
Rgcc
|
regulator of cell cycle |
chr17_-_26201328 | 17.79 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chrX_+_73639414 | 17.18 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr19_+_60755947 | 16.75 |
ENSMUST00000088237.4
|
Nanos1
|
nanos homolog 1 (Drosophila) |
chr11_+_24078022 | 16.36 |
ENSMUST00000000881.6
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr7_+_117380937 | 15.61 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr12_+_24831583 | 15.60 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr7_-_142578139 | 15.40 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr9_-_44288535 | 15.26 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr11_-_116581446 | 15.08 |
ENSMUST00000082152.4
|
Ube2o
|
ubiquitin-conjugating enzyme E2O |
chr11_+_95009852 | 14.84 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr4_+_11191726 | 14.51 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr4_+_127169131 | 14.26 |
ENSMUST00000046659.7
|
Dlgap3
|
discs, large (Drosophila) homolog-associated protein 3 |
chr16_-_22163299 | 14.24 |
ENSMUST00000100052.4
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr19_+_47178820 | 14.21 |
ENSMUST00000111808.3
|
Neurl1a
|
neuralized homolog 1A (Drosophila) |
chr18_-_58209926 | 14.04 |
ENSMUST00000025497.6
|
Fbn2
|
fibrillin 2 |
chr12_-_109068173 | 13.60 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr2_+_156840077 | 13.52 |
ENSMUST00000081335.6
ENSMUST00000073352.3 |
Tgif2
|
TGFB-induced factor homeobox 2 |
chr17_-_26201363 | 13.35 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr2_-_153529941 | 13.14 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr3_-_100489324 | 13.13 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr11_+_11685909 | 13.10 |
ENSMUST00000065433.5
|
Ikzf1
|
IKAROS family zinc finger 1 |
chrX_-_73660047 | 12.96 |
ENSMUST00000114472.1
|
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr8_-_121907678 | 12.92 |
ENSMUST00000045557.9
|
Slc7a5
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
chr2_-_102451792 | 12.74 |
ENSMUST00000099678.3
|
Fjx1
|
four jointed box 1 (Drosophila) |
chr3_-_69044697 | 12.65 |
ENSMUST00000136512.1
ENSMUST00000143454.1 ENSMUST00000107802.1 |
Trim59
|
tripartite motif-containing 59 |
chr10_-_80577285 | 12.58 |
ENSMUST00000038558.8
|
Klf16
|
Kruppel-like factor 16 |
chr4_+_129985098 | 12.57 |
ENSMUST00000106017.1
ENSMUST00000121049.1 |
Bai2
|
brain-specific angiogenesis inhibitor 2 |
chr19_+_7268296 | 12.56 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr8_+_83997613 | 12.35 |
ENSMUST00000095228.3
|
Samd1
|
sterile alpha motif domain containing 1 |
chr11_-_12026732 | 12.23 |
ENSMUST00000143915.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr2_-_163918683 | 12.19 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr6_+_4747306 | 12.19 |
ENSMUST00000175823.1
ENSMUST00000176204.1 ENSMUST00000166678.1 |
Peg10
|
paternally expressed 10 |
chr17_-_25433775 | 12.09 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr8_-_123859423 | 12.06 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr5_+_137288273 | 11.96 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr11_+_74619594 | 11.82 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chr11_-_94474088 | 11.57 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr11_+_62077018 | 11.53 |
ENSMUST00000092415.5
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr3_+_68869563 | 11.53 |
ENSMUST00000054551.2
|
1110032F04Rik
|
RIKEN cDNA 1110032F04 gene |
chr15_+_78913916 | 11.51 |
ENSMUST00000089378.4
|
Pdxp
|
pyridoxal (pyridoxine, vitamin B6) phosphatase |
chr8_+_105518736 | 11.41 |
ENSMUST00000034363.5
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr17_+_28801090 | 11.40 |
ENSMUST00000004985.9
|
Brpf3
|
bromodomain and PHD finger containing, 3 |
chr11_-_12026237 | 11.25 |
ENSMUST00000150972.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr10_-_30803075 | 11.16 |
ENSMUST00000068567.4
|
Ncoa7
|
nuclear receptor coactivator 7 |
chr11_+_102604370 | 11.10 |
ENSMUST00000057893.5
|
Fzd2
|
frizzled homolog 2 (Drosophila) |
chr7_-_142578093 | 11.06 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr2_-_180642681 | 10.96 |
ENSMUST00000037877.10
|
Tcfl5
|
transcription factor-like 5 (basic helix-loop-helix) |
chr1_-_193035651 | 10.92 |
ENSMUST00000016344.7
|
Syt14
|
synaptotagmin XIV |
chr10_+_82985473 | 10.72 |
ENSMUST00000040110.7
|
Chst11
|
carbohydrate sulfotransferase 11 |
chr16_+_17646464 | 10.67 |
ENSMUST00000056962.4
|
Ccdc74a
|
coiled-coil domain containing 74A |
chrX_-_52613936 | 10.61 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr4_+_11191354 | 10.60 |
ENSMUST00000170901.1
|
Ccne2
|
cyclin E2 |
chr13_-_68999518 | 10.55 |
ENSMUST00000022013.7
|
Adcy2
|
adenylate cyclase 2 |
chr11_+_7063423 | 10.54 |
ENSMUST00000020706.4
|
Adcy1
|
adenylate cyclase 1 |
chr9_-_56635624 | 10.50 |
ENSMUST00000114256.1
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chrX_+_136270302 | 10.50 |
ENSMUST00000113112.1
|
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr8_+_93810832 | 10.46 |
ENSMUST00000034198.8
ENSMUST00000125716.1 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr6_+_134929118 | 10.42 |
ENSMUST00000185152.1
ENSMUST00000184504.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr6_+_134929089 | 10.37 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr16_+_18127607 | 10.35 |
ENSMUST00000059589.5
|
Rtn4r
|
reticulon 4 receptor |
chr12_+_110279228 | 10.33 |
ENSMUST00000097228.4
|
Dio3
|
deiodinase, iodothyronine type III |
chrX_-_136068236 | 10.22 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chrX_-_52613913 | 10.16 |
ENSMUST00000069360.7
|
Gpc3
|
glypican 3 |
chr16_+_17646564 | 9.94 |
ENSMUST00000182117.1
ENSMUST00000182671.1 ENSMUST00000182344.1 |
Ccdc74a
|
coiled-coil domain containing 74A |
chr4_+_46450892 | 9.89 |
ENSMUST00000102926.4
|
Anp32b
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
chr4_+_46039202 | 9.81 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr2_-_91931774 | 9.81 |
ENSMUST00000069423.6
|
Mdk
|
midkine |
chr2_+_103970115 | 9.81 |
ENSMUST00000111143.1
ENSMUST00000138815.1 |
Lmo2
|
LIM domain only 2 |
chr10_-_5805412 | 9.74 |
ENSMUST00000019907.7
|
Fbxo5
|
F-box protein 5 |
chr1_+_136131382 | 9.62 |
ENSMUST00000075164.4
|
Kif21b
|
kinesin family member 21B |
chr13_-_107022027 | 9.61 |
ENSMUST00000117539.1
ENSMUST00000122233.1 ENSMUST00000022204.9 ENSMUST00000159772.1 |
Kif2a
|
kinesin family member 2A |
chr2_-_152398046 | 9.61 |
ENSMUST00000063332.8
ENSMUST00000182625.1 |
Sox12
|
SRY-box containing gene 12 |
chr5_-_100159261 | 9.51 |
ENSMUST00000139520.1
|
Tmem150c
|
transmembrane protein 150C |
chr12_-_79007276 | 9.43 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr2_+_145167706 | 9.43 |
ENSMUST00000110007.1
|
Slc24a3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
chr12_-_112929415 | 9.42 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr13_+_48662989 | 9.29 |
ENSMUST00000021813.4
|
Barx1
|
BarH-like homeobox 1 |
chr7_-_134225088 | 9.25 |
ENSMUST00000067680.4
|
Adam12
|
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
chr11_+_3290300 | 9.18 |
ENSMUST00000057089.6
ENSMUST00000093402.5 |
Patz1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr5_+_141241490 | 9.17 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr2_+_118111876 | 9.10 |
ENSMUST00000039559.8
|
Thbs1
|
thrombospondin 1 |
chr2_+_127336152 | 9.09 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr1_-_182019927 | 9.09 |
ENSMUST00000078719.6
ENSMUST00000111030.3 ENSMUST00000177811.1 ENSMUST00000111024.3 ENSMUST00000111025.2 |
Enah
|
enabled homolog (Drosophila) |
chr7_+_27258725 | 9.06 |
ENSMUST00000079258.6
|
Numbl
|
numb-like |
chr11_+_103171081 | 9.03 |
ENSMUST00000042286.5
|
Fmnl1
|
formin-like 1 |
chr1_+_75382114 | 9.03 |
ENSMUST00000113590.1
ENSMUST00000148515.1 |
Speg
|
SPEG complex locus |
chr10_-_21160925 | 9.00 |
ENSMUST00000020158.6
|
Myb
|
myeloblastosis oncogene |
chrX_-_136215443 | 8.95 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr2_-_131562283 | 8.87 |
ENSMUST00000103184.3
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr6_+_99692679 | 8.86 |
ENSMUST00000101122.1
|
Gpr27
|
G protein-coupled receptor 27 |
chr2_-_26021532 | 8.83 |
ENSMUST00000136750.1
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr10_-_76961788 | 8.82 |
ENSMUST00000001148.4
ENSMUST00000105411.2 |
Pcbp3
|
poly(rC) binding protein 3 |
chr7_-_133123770 | 8.76 |
ENSMUST00000164896.1
ENSMUST00000171968.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr7_-_120982260 | 8.75 |
ENSMUST00000033169.8
|
Cdr2
|
cerebellar degeneration-related 2 |
chr11_+_24080664 | 8.73 |
ENSMUST00000118955.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr2_-_91931675 | 8.71 |
ENSMUST00000111309.1
|
Mdk
|
midkine |
chr5_-_52566264 | 8.67 |
ENSMUST00000039750.5
|
Lgi2
|
leucine-rich repeat LGI family, member 2 |
chr7_+_141061274 | 8.67 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr4_+_115057683 | 8.66 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr17_-_56830916 | 8.64 |
ENSMUST00000002444.7
ENSMUST00000086801.5 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr5_+_99979061 | 8.62 |
ENSMUST00000046721.1
|
4930524J08Rik
|
RIKEN cDNA 4930524J08 gene |
chrX_+_8271133 | 8.58 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chr19_+_6084983 | 8.53 |
ENSMUST00000025704.2
|
Cdca5
|
cell division cycle associated 5 |
chr9_-_57836706 | 8.53 |
ENSMUST00000164010.1
ENSMUST00000171444.1 ENSMUST00000098686.3 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr10_-_79874233 | 8.52 |
ENSMUST00000166023.1
ENSMUST00000167707.1 ENSMUST00000165601.1 |
BC005764
|
cDNA sequence BC005764 |
chr2_-_157079212 | 8.52 |
ENSMUST00000069098.6
|
Soga1
|
suppressor of glucose, autophagy associated 1 |
chr5_-_24351604 | 8.52 |
ENSMUST00000036092.7
|
Kcnh2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr16_-_18629864 | 8.49 |
ENSMUST00000096987.5
|
Sept5
|
septin 5 |
chr6_-_30958990 | 8.47 |
ENSMUST00000101589.3
|
Klf14
|
Kruppel-like factor 14 |
chr9_-_119578981 | 8.46 |
ENSMUST00000117911.1
ENSMUST00000120420.1 |
Scn5a
|
sodium channel, voltage-gated, type V, alpha |
chr11_+_24078173 | 8.44 |
ENSMUST00000109514.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr10_-_19851459 | 8.42 |
ENSMUST00000059805.4
|
Slc35d3
|
solute carrier family 35, member D3 |
chr13_+_73467197 | 8.39 |
ENSMUST00000022099.8
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1 |
chr3_+_10012548 | 8.37 |
ENSMUST00000029046.8
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr11_-_96005872 | 8.35 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chr15_+_80091320 | 8.33 |
ENSMUST00000009728.6
ENSMUST00000009727.5 |
Syngr1
|
synaptogyrin 1 |
chr5_-_140649018 | 8.30 |
ENSMUST00000042661.3
|
Ttyh3
|
tweety homolog 3 (Drosophila) |
chrX_-_7967817 | 8.29 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr10_-_116473875 | 8.24 |
ENSMUST00000068233.4
|
Kcnmb4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr11_+_120949053 | 8.24 |
ENSMUST00000154187.1
ENSMUST00000100130.3 ENSMUST00000129473.1 ENSMUST00000168579.1 |
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr8_+_57511833 | 8.22 |
ENSMUST00000067925.6
|
Hmgb2
|
high mobility group box 2 |
chr4_-_88033328 | 8.21 |
ENSMUST00000078090.5
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr9_-_44234014 | 8.19 |
ENSMUST00000037644.6
|
Cbl
|
Casitas B-lineage lymphoma |
chr17_-_25727364 | 8.16 |
ENSMUST00000170070.1
ENSMUST00000048054.7 |
Chtf18
|
CTF18, chromosome transmission fidelity factor 18 |
chr7_-_133123160 | 8.14 |
ENSMUST00000166439.1
|
Ctbp2
|
C-terminal binding protein 2 |
chr2_-_33431324 | 8.07 |
ENSMUST00000113158.1
|
Zbtb34
|
zinc finger and BTB domain containing 34 |
chr11_-_69560186 | 8.07 |
ENSMUST00000004036.5
|
Efnb3
|
ephrin B3 |
chr4_-_133967235 | 8.05 |
ENSMUST00000123234.1
|
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chrX_+_159255919 | 8.02 |
ENSMUST00000112492.1
|
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr2_-_153444441 | 8.02 |
ENSMUST00000109784.1
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr4_-_152477433 | 8.01 |
ENSMUST00000159186.1
ENSMUST00000162017.1 ENSMUST00000030768.2 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chrX_+_8271642 | 7.90 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr1_-_52232296 | 7.90 |
ENSMUST00000114512.1
|
Gls
|
glutaminase |
chr10_+_43579161 | 7.82 |
ENSMUST00000058714.8
|
Cd24a
|
CD24a antigen |
chr1_-_119053619 | 7.80 |
ENSMUST00000062483.8
|
Gli2
|
GLI-Kruppel family member GLI2 |
chr4_+_48585193 | 7.78 |
ENSMUST00000107703.1
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr2_+_153492790 | 7.69 |
ENSMUST00000109783.1
|
4930404H24Rik
|
RIKEN cDNA 4930404H24 gene |
chr11_-_87359011 | 7.66 |
ENSMUST00000055438.4
|
Ppm1e
|
protein phosphatase 1E (PP2C domain containing) |
chr2_-_26021679 | 7.66 |
ENSMUST00000036509.7
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr2_-_73775341 | 7.64 |
ENSMUST00000112024.3
ENSMUST00000166199.1 ENSMUST00000180045.1 |
Chn1
|
chimerin (chimaerin) 1 |
chr2_-_24763047 | 7.64 |
ENSMUST00000100348.3
ENSMUST00000041342.5 ENSMUST00000114447.1 ENSMUST00000102939.2 ENSMUST00000070864.7 |
Cacna1b
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
chr15_-_73184840 | 7.62 |
ENSMUST00000044113.10
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr6_-_38299236 | 7.62 |
ENSMUST00000058524.2
|
Zc3hav1l
|
zinc finger CCCH-type, antiviral 1-like |
chr11_+_53519871 | 7.60 |
ENSMUST00000120878.2
|
Sept8
|
septin 8 |
chr3_-_86920830 | 7.60 |
ENSMUST00000029719.8
|
Dclk2
|
doublecortin-like kinase 2 |
chr8_-_122551316 | 7.60 |
ENSMUST00000067252.7
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1 |
chr4_+_115057410 | 7.57 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_+_35121126 | 7.54 |
ENSMUST00000069837.3
|
Slit3
|
slit homolog 3 (Drosophila) |
chr8_-_105637403 | 7.51 |
ENSMUST00000182046.1
|
Gm5914
|
predicted gene 5914 |
chr4_+_62965560 | 7.50 |
ENSMUST00000030043.6
ENSMUST00000107415.1 ENSMUST00000064814.5 |
Zfp618
|
zinc finger protein 618 |
chrX_-_142966709 | 7.49 |
ENSMUST00000041317.2
|
Ammecr1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr15_+_80173642 | 7.49 |
ENSMUST00000044970.6
|
Mgat3
|
mannoside acetylglucosaminyltransferase 3 |
chrX_+_160390684 | 7.47 |
ENSMUST00000112408.2
ENSMUST00000112402.1 ENSMUST00000112401.1 ENSMUST00000112400.1 ENSMUST00000112405.2 ENSMUST00000112404.2 ENSMUST00000146805.1 |
Gpr64
|
G protein-coupled receptor 64 |
chr12_+_5375870 | 7.46 |
ENSMUST00000037953.6
|
2810032G03Rik
|
RIKEN cDNA 2810032G03 gene |
chr4_+_129984833 | 7.42 |
ENSMUST00000120204.1
|
Bai2
|
brain-specific angiogenesis inhibitor 2 |
chr4_+_107802277 | 7.39 |
ENSMUST00000106733.2
ENSMUST00000030356.3 ENSMUST00000106732.2 ENSMUST00000126573.1 |
Lrp8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
chr4_-_133967893 | 7.39 |
ENSMUST00000100472.3
ENSMUST00000136327.1 |
Hmgn2
|
high mobility group nucleosomal binding domain 2 |
chr4_+_124700700 | 7.36 |
ENSMUST00000106199.3
ENSMUST00000038684.5 |
Fhl3
|
four and a half LIM domains 3 |
chr7_+_113513854 | 7.35 |
ENSMUST00000067929.8
ENSMUST00000129087.1 ENSMUST00000164745.1 ENSMUST00000136158.1 |
Far1
|
fatty acyl CoA reductase 1 |
chr3_+_88532314 | 7.34 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chr17_-_46629420 | 7.33 |
ENSMUST00000044442.8
|
Ptk7
|
PTK7 protein tyrosine kinase 7 |
chr8_+_106168857 | 7.32 |
ENSMUST00000034378.3
|
Slc7a6
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 |
chr1_-_119053339 | 7.32 |
ENSMUST00000161301.1
ENSMUST00000161451.1 ENSMUST00000162607.1 |
Gli2
|
GLI-Kruppel family member GLI2 |
chrX_+_162760427 | 7.31 |
ENSMUST00000112326.1
|
Rbbp7
|
retinoblastoma binding protein 7 |
chr5_+_33820695 | 7.29 |
ENSMUST00000075812.4
ENSMUST00000114397.2 ENSMUST00000155880.1 |
Whsc1
|
Wolf-Hirschhorn syndrome candidate 1 (human) |
chr4_+_120666562 | 7.28 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr5_-_22344690 | 7.26 |
ENSMUST00000062372.7
ENSMUST00000161356.1 |
Reln
|
reelin |
chrX_+_20425688 | 7.23 |
ENSMUST00000115384.2
|
Phf16
|
PHD finger protein 16 |
chr11_-_120348475 | 7.23 |
ENSMUST00000062147.7
ENSMUST00000128055.1 |
Actg1
|
actin, gamma, cytoplasmic 1 |
chr7_+_99535652 | 7.22 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr1_-_184999549 | 7.18 |
ENSMUST00000027929.4
|
Mark1
|
MAP/microtubule affinity-regulating kinase 1 |
chr2_+_130295148 | 7.14 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr4_+_52439235 | 7.14 |
ENSMUST00000117280.1
ENSMUST00000102915.3 ENSMUST00000142227.1 |
Smc2
|
structural maintenance of chromosomes 2 |
chr13_+_117220584 | 7.13 |
ENSMUST00000022242.7
|
Emb
|
embigin |
chr8_-_80057989 | 7.11 |
ENSMUST00000079038.2
|
Hhip
|
Hedgehog-interacting protein |
chr11_+_53519725 | 7.10 |
ENSMUST00000108987.1
ENSMUST00000121334.1 ENSMUST00000117061.1 |
Sept8
|
septin 8 |
chr2_-_150668198 | 7.08 |
ENSMUST00000028944.3
|
Acss1
|
acyl-CoA synthetase short-chain family member 1 |
chr14_+_99298652 | 7.08 |
ENSMUST00000005279.6
|
Klf5
|
Kruppel-like factor 5 |
chr19_-_4615453 | 7.07 |
ENSMUST00000053597.2
|
Lrfn4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr12_-_27342696 | 7.05 |
ENSMUST00000079063.5
|
Sox11
|
SRY-box containing gene 11 |
chr7_+_19282613 | 7.05 |
ENSMUST00000032559.9
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr15_+_39198244 | 7.01 |
ENSMUST00000082054.5
ENSMUST00000042917.9 |
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr10_+_121033960 | 7.00 |
ENSMUST00000020439.4
ENSMUST00000175867.1 |
Wif1
|
Wnt inhibitory factor 1 |
chr5_+_37242025 | 7.00 |
ENSMUST00000114158.2
|
Crmp1
|
collapsin response mediator protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.2 | 81.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
10.0 | 40.1 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
6.4 | 19.2 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
6.0 | 18.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
6.0 | 6.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
5.9 | 17.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.8 | 19.1 | GO:0060032 | notochord regression(GO:0060032) |
4.7 | 51.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
4.6 | 4.6 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
4.3 | 4.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
4.3 | 12.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
4.2 | 12.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
4.1 | 32.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
3.9 | 23.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
3.9 | 7.8 | GO:0015675 | nickel cation transport(GO:0015675) |
3.9 | 15.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.8 | 15.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
3.8 | 11.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
3.8 | 15.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
3.6 | 25.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.5 | 17.6 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
3.5 | 17.5 | GO:0071104 | response to interleukin-9(GO:0071104) |
3.5 | 24.3 | GO:0030421 | defecation(GO:0030421) |
3.5 | 3.5 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
3.4 | 10.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
3.4 | 10.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
3.4 | 10.1 | GO:0030221 | basophil differentiation(GO:0030221) |
3.3 | 13.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
3.3 | 13.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
3.3 | 13.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.3 | 3.3 | GO:0051309 | female meiosis chromosome separation(GO:0051309) |
3.3 | 13.0 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
3.1 | 12.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
3.1 | 18.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
3.1 | 9.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
3.0 | 9.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
3.0 | 9.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
3.0 | 15.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
3.0 | 9.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
3.0 | 9.1 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
3.0 | 15.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.0 | 23.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.9 | 11.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.9 | 17.5 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
2.9 | 8.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
2.9 | 8.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.9 | 8.6 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
2.8 | 2.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
2.8 | 13.9 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.8 | 11.1 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
2.7 | 35.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.7 | 27.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.7 | 5.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.7 | 10.7 | GO:0006272 | leading strand elongation(GO:0006272) |
2.7 | 10.7 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
2.6 | 7.9 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
2.6 | 10.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
2.6 | 10.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
2.6 | 2.6 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
2.6 | 98.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
2.6 | 2.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
2.6 | 10.3 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.6 | 15.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.6 | 7.7 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
2.5 | 12.6 | GO:0035989 | tendon development(GO:0035989) |
2.5 | 10.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.5 | 10.0 | GO:0010286 | heat acclimation(GO:0010286) |
2.4 | 4.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.4 | 12.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.4 | 4.8 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.4 | 23.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.3 | 18.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.3 | 6.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
2.2 | 6.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
2.2 | 8.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.2 | 4.4 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
2.2 | 11.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.2 | 10.8 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.2 | 6.5 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
2.1 | 2.1 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
2.1 | 4.3 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
2.1 | 4.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.1 | 22.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.1 | 16.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.0 | 2.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.0 | 6.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
2.0 | 8.1 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
2.0 | 12.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.0 | 8.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
2.0 | 4.0 | GO:0060022 | hard palate development(GO:0060022) |
2.0 | 6.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.0 | 6.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
2.0 | 7.9 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
2.0 | 2.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
2.0 | 2.0 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
2.0 | 15.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.0 | 17.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.9 | 3.9 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
1.9 | 5.8 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
1.9 | 11.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.9 | 5.6 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.9 | 3.8 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.8 | 3.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.8 | 3.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
1.8 | 1.8 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
1.8 | 9.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.8 | 18.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.8 | 14.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.8 | 7.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.8 | 10.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.8 | 5.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.8 | 26.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.7 | 8.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.7 | 26.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.7 | 6.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.7 | 5.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.7 | 8.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.7 | 10.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.7 | 12.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.7 | 8.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.7 | 6.8 | GO:0051590 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
1.7 | 5.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.7 | 5.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.7 | 11.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.7 | 3.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
1.7 | 8.3 | GO:0044849 | estrous cycle(GO:0044849) |
1.7 | 8.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.6 | 14.8 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
1.6 | 9.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.6 | 9.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.6 | 4.8 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
1.6 | 6.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.6 | 4.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.6 | 14.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.6 | 6.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.6 | 11.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.6 | 7.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 | 6.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.6 | 4.7 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.6 | 4.7 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
1.5 | 7.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
1.5 | 10.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.5 | 9.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.5 | 1.5 | GO:0061511 | centriole elongation(GO:0061511) |
1.5 | 3.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.5 | 4.5 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.5 | 6.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
1.5 | 3.0 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.5 | 4.5 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
1.5 | 11.9 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
1.5 | 4.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.5 | 4.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.5 | 4.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.4 | 21.7 | GO:0015816 | glycine transport(GO:0015816) |
1.4 | 13.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
1.4 | 10.0 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.4 | 10.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.4 | 4.2 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
1.4 | 5.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.4 | 5.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.4 | 25.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.4 | 8.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.4 | 4.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
1.4 | 11.2 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
1.4 | 4.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.4 | 4.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
1.4 | 5.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.4 | 2.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.4 | 5.5 | GO:0007412 | axon target recognition(GO:0007412) |
1.4 | 4.1 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
1.4 | 2.7 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.4 | 1.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.4 | 9.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.3 | 1.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 | 9.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 6.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.3 | 9.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.3 | 5.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.3 | 4.0 | GO:1990523 | bone regeneration(GO:1990523) |
1.3 | 6.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.3 | 21.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.3 | 5.3 | GO:0021586 | pons maturation(GO:0021586) |
1.3 | 1.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.3 | 1.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
1.3 | 6.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.3 | 7.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
1.3 | 3.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 2.6 | GO:0002215 | defense response to nematode(GO:0002215) |
1.3 | 3.9 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
1.3 | 1.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.3 | 5.2 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 3.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.3 | 7.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.3 | 10.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.3 | 2.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.3 | 3.8 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
1.3 | 11.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.3 | 31.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
1.3 | 5.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.3 | 6.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.2 | 5.0 | GO:0015825 | L-serine transport(GO:0015825) |
1.2 | 7.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.2 | 54.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.2 | 9.9 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.2 | 8.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.2 | 23.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.2 | 1.2 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.2 | 4.8 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
1.2 | 2.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.2 | 32.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.2 | 4.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.2 | 2.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.2 | 4.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.2 | 3.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.2 | 19.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.2 | 3.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.2 | 3.5 | GO:0051794 | regulation of catagen(GO:0051794) |
1.2 | 10.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.1 | 5.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.1 | 2.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.1 | 3.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.1 | 3.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.1 | 5.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.1 | 4.5 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
1.1 | 6.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.1 | 2.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
1.1 | 21.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.1 | 4.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.1 | 3.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.1 | 7.7 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
1.1 | 12.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.1 | 4.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.1 | 3.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.1 | 30.6 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.1 | 10.9 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
1.1 | 1.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 3.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 3.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
1.1 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.1 | 7.6 | GO:0016266 | O-glycan processing(GO:0016266) |
1.1 | 8.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.1 | 2.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.1 | 4.3 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
1.1 | 6.4 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 15.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.1 | 5.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.1 | 44.8 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
1.1 | 1.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
1.1 | 13.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.1 | 3.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.1 | 3.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
1.1 | 7.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.1 | 12.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.1 | 6.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.1 | 6.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 4.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.0 | 8.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.0 | 2.1 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.0 | 3.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
1.0 | 4.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.0 | 3.1 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.0 | 2.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.0 | 6.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.0 | 7.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.0 | 20.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.0 | 3.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.0 | 13.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 2.0 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.0 | 4.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.0 | 5.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.0 | 3.0 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
1.0 | 4.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.0 | 6.0 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.0 | 3.0 | GO:0060435 | bronchiole development(GO:0060435) |
1.0 | 5.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.0 | 3.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.0 | 1.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.0 | 3.0 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
1.0 | 8.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.0 | 5.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.0 | 5.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.0 | 4.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.0 | 4.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.0 | 6.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 2.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 3.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.0 | 2.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.0 | 2.0 | GO:0033058 | directional locomotion(GO:0033058) |
1.0 | 2.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.0 | 21.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
1.0 | 2.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.0 | 2.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.0 | 4.8 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.0 | 2.9 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
1.0 | 1.0 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.0 | 1.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.9 | 10.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 10.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.9 | 2.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.9 | 1.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.9 | 8.4 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.9 | 1.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 5.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.9 | 2.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.9 | 2.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.9 | 2.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.9 | 0.9 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.9 | 2.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.9 | 7.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.9 | 35.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.9 | 2.7 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.9 | 19.0 | GO:0051298 | centrosome duplication(GO:0051298) |
0.9 | 3.6 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 4.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 0.9 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.9 | 2.7 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.9 | 1.8 | GO:0072104 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.9 | 0.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 8.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 6.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 9.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.9 | 1.8 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.9 | 5.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.9 | 2.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.9 | 1.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.9 | 1.7 | GO:0014857 | skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.9 | 2.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.9 | 17.4 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.9 | 8.6 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.9 | 3.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.9 | 3.4 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.9 | 12.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.9 | 6.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.9 | 17.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.9 | 1.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.9 | 3.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 0.8 | GO:0061193 | taste bud development(GO:0061193) |
0.8 | 6.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 1.7 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.8 | 16.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 2.5 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.8 | 17.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.8 | 2.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.8 | 4.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.8 | 2.5 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.8 | 5.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 1.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.8 | 1.6 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.8 | 4.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 4.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.8 | 3.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.8 | 0.8 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.8 | 2.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 0.8 | GO:0032796 | uropod organization(GO:0032796) |
0.8 | 12.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.8 | 6.4 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 2.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.8 | 2.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 3.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.8 | 4.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 3.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.8 | 1.6 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.8 | 3.1 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 3.9 | GO:1901563 | response to camptothecin(GO:1901563) |
0.8 | 4.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.8 | 5.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.8 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.8 | 1.5 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.8 | 10.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 3.1 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.8 | 24.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.8 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.8 | 7.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 11.5 | GO:0007614 | short-term memory(GO:0007614) |
0.8 | 3.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.8 | 3.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.8 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.8 | 3.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 3.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.8 | 12.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.8 | 3.0 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.8 | 1.5 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.8 | 0.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.8 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 4.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 3.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.7 | 3.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.7 | 2.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.7 | 2.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 4.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 1.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.7 | 3.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.7 | 1.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 4.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.7 | 2.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 2.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.7 | 22.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.7 | 2.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.7 | 1.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.7 | 4.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 5.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 23.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.7 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.8 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 0.7 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.7 | 7.0 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.7 | 1.4 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.7 | 1.4 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.7 | 10.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 2.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.7 | 15.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 3.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.7 | 2.0 | GO:0060912 | central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.7 | 3.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 3.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 4.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 8.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.7 | 4.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 18.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.7 | 2.7 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.7 | 0.7 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.7 | 2.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.7 | 7.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 1.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.7 | 2.0 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.7 | 2.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 15.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 1.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 2.0 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.6 | 4.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.6 | 7.1 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.6 | 8.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.6 | 3.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 2.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 0.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.6 | 3.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 0.6 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.6 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 1.9 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.6 | 5.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 6.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.6 | 1.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.6 | 2.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 8.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.6 | 1.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 4.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 5.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 1.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.6 | 3.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 5.5 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.6 | 0.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.6 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.6 | 7.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 1.8 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.6 | 4.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.6 | 1.8 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.6 | 2.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.6 | 1.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) positive regulation of anagen(GO:0051885) |
0.6 | 1.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.6 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 3.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 10.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 2.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 1.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 2.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 | 5.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 12.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 3.5 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.6 | 3.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 11.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.6 | 8.6 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.6 | 8.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.6 | 2.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.6 | 4.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 2.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 1.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 2.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.6 | 2.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.6 | 10.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.6 | 2.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 2.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.6 | 1.1 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.6 | 1.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.6 | 0.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.5 | 2.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 1.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.5 | 4.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 4.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 2.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 5.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.5 | 3.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 1.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.5 | 0.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 1.1 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.5 | 0.5 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.5 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 1.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.5 | 2.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 9.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 0.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.5 | 0.5 | GO:0099548 | trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
0.5 | 6.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 1.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.5 | 3.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 3.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 0.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 4.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 1.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 1.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 2.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 3.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 16.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.5 | 1.0 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.5 | 1.0 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.5 | 1.0 | GO:0009157 | dTMP biosynthetic process(GO:0006231) deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) dTMP metabolic process(GO:0046073) |
0.5 | 4.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 1.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.5 | 19.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 2.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.5 | 1.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.5 | 3.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.5 | 9.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 3.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 2.0 | GO:0032899 | regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
0.5 | 3.9 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 2.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 2.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.5 | 20.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 1.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 2.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 4.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.5 | 1.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.5 | 2.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.5 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 0.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.5 | 1.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.5 | 1.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 7.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 1.8 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.4 | 8.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 3.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 3.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 0.9 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.4 | 1.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of muscle filament sliding speed(GO:0032972) |
0.4 | 1.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 3.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 0.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 2.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 0.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 0.4 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.4 | 1.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.4 | 1.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.4 | 2.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 14.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 0.9 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.4 | 1.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 8.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 1.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 1.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 1.2 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.4 | 3.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 3.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.4 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 8.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 7.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 0.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.4 | 3.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 2.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.4 | 2.4 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.4 | 1.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 2.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 2.8 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.4 | 6.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.4 | 1.6 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 1.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 0.4 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.4 | 7.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 2.0 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.4 | 1.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.4 | 2.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.6 | GO:0042148 | strand invasion(GO:0042148) |
0.4 | 0.8 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.4 | 7.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 5.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 1.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.4 | 0.8 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.4 | 2.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 1.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 0.8 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.4 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 1.9 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.4 | 1.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.4 | 0.8 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.4 | 1.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 7.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.4 | 0.4 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 1.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 0.4 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.4 | 0.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 3.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 2.3 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.4 | 2.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 1.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 5.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 1.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 1.5 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 4.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 5.9 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.4 | 2.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 4.7 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.4 | 7.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.4 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 1.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 0.7 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 6.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 2.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 0.4 | GO:0060577 | pulmonary vein morphogenesis(GO:0060577) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 4.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.3 | 1.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 5.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.3 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.3 | 4.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 2.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 3.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 1.7 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.3 | 1.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 1.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 1.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 0.7 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 3.4 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.3 | 2.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 1.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.3 | 2.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.7 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.3 | 0.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 1.0 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.3 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 1.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.3 | 3.9 | GO:0048536 | spleen development(GO:0048536) |
0.3 | 3.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 1.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 14.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 3.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 0.3 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.3 | 0.6 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 1.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.3 | 1.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 1.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.3 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 2.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 2.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 3.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 20.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 4.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 2.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 2.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 6.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 3.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 1.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 8.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 4.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.3 | 8.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 1.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 1.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 2.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.3 | 0.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.3 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 1.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.6 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.3 | 2.9 | GO:0035878 | nail development(GO:0035878) |
0.3 | 4.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 4.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.6 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 0.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 0.6 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.3 | 1.5 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.3 | 1.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.3 | 1.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 1.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.3 | 2.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 1.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 4.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.3 | 1.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 0.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) positive regulation of Schwann cell migration(GO:1900149) |
0.3 | 0.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 1.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 1.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.3 | 0.8 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.3 | 1.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.3 | 1.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 0.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 5.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 0.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 3.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 4.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 1.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.3 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.5 | GO:0034773 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.3 | 1.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 1.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.3 | 1.6 | GO:1901906 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 3.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 0.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 1.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 2.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.3 | 1.8 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.3 | 1.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.3 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 2.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 3.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 4.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 1.5 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 3.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.7 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 0.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.2 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 1.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 2.6 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 1.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 2.6 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.2 | 2.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 13.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 13.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 3.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 3.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 5.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 7.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 2.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 1.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 1.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 3.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.6 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 1.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 10.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 3.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 1.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 1.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 3.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 1.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.7 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 2.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 3.7 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.2 | 11.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 2.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 3.9 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.2 | 10.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 1.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 1.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 4.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 1.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 2.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 2.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 4.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.0 | GO:0045187 | circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.2 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.2 | 2.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.4 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.2 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.6 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 1.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 1.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.6 | GO:0019085 | early viral transcription(GO:0019085) |
0.2 | 0.8 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 1.8 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 0.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 5.4 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.2 | 3.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 18.9 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 1.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 1.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 3.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.5 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 1.0 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.2 | 0.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.7 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.2 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 2.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 1.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.2 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.2 | 0.5 | GO:0007309 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.2 | 1.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.8 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 1.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 1.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 2.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.1 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.1 | 1.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 2.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 1.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.6 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 1.0 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 2.7 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 2.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 1.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 1.5 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.6 | GO:2000677 | regulation of transcription regulatory region DNA binding(GO:2000677) |
0.1 | 0.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 3.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 1.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 3.7 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 7.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 2.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 1.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 5.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 9.3 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 5.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 6.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 2.0 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 1.7 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.5 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 2.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 1.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 3.9 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.7 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.3 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 | 0.7 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 1.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 2.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 3.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 4.8 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.9 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 1.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 1.3 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.8 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0071287 | copper ion export(GO:0060003) cellular response to manganese ion(GO:0071287) |
0.1 | 0.2 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 1.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.8 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.1 | 0.2 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 0.1 | GO:2000409 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.1 | 1.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.1 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:2000583 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.5 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.1 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 2.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.6 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.4 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.1 | 0.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.3 | GO:0060795 | cell fate commitment involved in formation of primary germ layer(GO:0060795) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 0.2 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.2 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 1.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 1.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.9 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 1.1 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.7 | GO:0051339 | regulation of lyase activity(GO:0051339) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.4 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.0 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.0 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.0 | 0.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.0 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.0 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.2 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.5 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 0.0 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
6.4 | 19.2 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
5.5 | 27.7 | GO:0031523 | Myb complex(GO:0031523) |
4.2 | 12.6 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
4.2 | 16.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
3.7 | 25.6 | GO:0001740 | Barr body(GO:0001740) |
3.2 | 9.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
3.2 | 15.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.1 | 31.1 | GO:0000796 | condensin complex(GO:0000796) |
3.1 | 21.4 | GO:0008091 | spectrin(GO:0008091) |
2.9 | 11.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.9 | 11.6 | GO:0043293 | apoptosome(GO:0043293) |
2.9 | 11.5 | GO:0014802 | terminal cisterna(GO:0014802) |
2.8 | 16.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.8 | 11.2 | GO:1902737 | dendritic filopodium(GO:1902737) |
2.7 | 8.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
2.6 | 10.3 | GO:0090537 | CERF complex(GO:0090537) |
2.4 | 9.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.4 | 11.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.4 | 14.1 | GO:0000235 | astral microtubule(GO:0000235) |
2.3 | 25.8 | GO:0001939 | female pronucleus(GO:0001939) |
2.3 | 9.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
2.2 | 15.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.2 | 6.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
2.1 | 6.2 | GO:1990423 | RZZ complex(GO:1990423) |
2.0 | 17.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.9 | 11.5 | GO:0098536 | deuterosome(GO:0098536) |
1.9 | 7.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.9 | 11.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.9 | 5.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.9 | 9.3 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
1.9 | 28.0 | GO:0042555 | MCM complex(GO:0042555) |
1.9 | 16.7 | GO:0008278 | cohesin complex(GO:0008278) |
1.9 | 9.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.8 | 5.3 | GO:0042583 | chromaffin granule(GO:0042583) |
1.7 | 5.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.7 | 1.7 | GO:0035101 | FACT complex(GO:0035101) |
1.7 | 23.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.6 | 4.9 | GO:0005940 | septin ring(GO:0005940) |
1.6 | 21.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.6 | 14.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.6 | 11.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.6 | 33.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.6 | 6.4 | GO:0060187 | cell pole(GO:0060187) |
1.6 | 6.4 | GO:0045160 | myosin I complex(GO:0045160) |
1.6 | 6.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.5 | 4.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.5 | 10.4 | GO:0005638 | lamin filament(GO:0005638) |
1.4 | 17.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.4 | 7.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.4 | 5.6 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 13.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.3 | 4.0 | GO:0071920 | cleavage body(GO:0071920) |
1.2 | 5.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.2 | 8.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.2 | 11.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 20.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.2 | 2.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.2 | 8.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.2 | 5.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.2 | 5.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.2 | 1.2 | GO:0044753 | amphisome(GO:0044753) |
1.2 | 7.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.2 | 9.3 | GO:0044327 | dendritic spine head(GO:0044327) |
1.2 | 7.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.2 | 18.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.2 | 4.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.2 | 4.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.1 | 16.0 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 5.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.1 | 2.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.1 | 3.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
1.1 | 11.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 5.5 | GO:0044301 | climbing fiber(GO:0044301) |
1.1 | 8.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.1 | 19.6 | GO:0097470 | ribbon synapse(GO:0097470) |
1.1 | 11.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.0 | 17.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
1.0 | 8.3 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 5.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.0 | 4.1 | GO:0072687 | meiotic spindle(GO:0072687) |
1.0 | 55.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.0 | 53.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.0 | 8.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.0 | 2.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 7.9 | GO:0070652 | HAUS complex(GO:0070652) |
1.0 | 8.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.0 | 2.9 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
1.0 | 23.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.0 | 2.9 | GO:0031251 | PAN complex(GO:0031251) |
0.9 | 8.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 8.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 3.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.9 | 3.8 | GO:0008623 | CHRAC(GO:0008623) |
0.9 | 16.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 4.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.9 | 2.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.9 | 6.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.9 | 2.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.9 | 2.7 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.9 | 16.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.9 | 22.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.9 | 3.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.9 | 3.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 3.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 15.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 4.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 2.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.8 | 4.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 9.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.8 | 23.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 7.9 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 5.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 2.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.8 | 7.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.8 | 17.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.8 | 3.1 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.8 | 1.5 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.7 | 53.7 | GO:0005844 | polysome(GO:0005844) |
0.7 | 8.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.7 | 9.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.7 | 4.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.7 | 4.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 18.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 3.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.7 | 64.8 | GO:0005814 | centriole(GO:0005814) |
0.7 | 10.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 4.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 7.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 4.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 9.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.7 | 6.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.7 | 4.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 7.3 | GO:0031105 | septin complex(GO:0031105) |
0.7 | 10.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.7 | 3.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 12.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.6 | 6.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 6.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 4.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.6 | 6.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 55.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 5.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.6 | 1.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.6 | 3.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 15.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 2.3 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.6 | 12.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 6.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 2.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 21.5 | GO:0043034 | costamere(GO:0043034) |
0.6 | 2.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 6.2 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 16.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 1.7 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.6 | 1.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 3.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 2.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 4.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 0.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 31.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 3.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 6.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.5 | 56.5 | GO:0000776 | kinetochore(GO:0000776) |
0.5 | 2.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 11.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 8.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 3.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.5 | 8.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 3.4 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 26.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 7.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 0.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 38.4 | GO:0016605 | PML body(GO:0016605) |
0.5 | 6.1 | GO:0001741 | XY body(GO:0001741) |
0.5 | 5.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 14.7 | GO:0002102 | podosome(GO:0002102) |
0.5 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 5.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 6.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 3.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 35.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.4 | 1.3 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 3.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 10.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 3.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 1.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 2.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.4 | 17.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 9.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 20.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 15.1 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 7.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 0.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.4 | 7.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 20.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 5.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 2.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 3.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 14.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 4.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 9.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.4 | 12.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 1.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 1.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 2.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 2.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 3.1 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 2.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 5.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 3.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 1.0 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 0.6 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.3 | 1.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 7.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 7.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 11.4 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 10.9 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 3.4 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.3 | 1.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 1.5 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 1.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.3 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 9.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.3 | 4.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 6.6 | GO:0005819 | spindle(GO:0005819) |
0.3 | 2.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 6.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 2.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 6.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 6.0 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 6.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 2.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 2.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 24.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.5 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 13.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 8.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 22.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 6.4 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 9.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 5.8 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 2.1 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 5.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.0 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 4.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 2.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 2.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 5.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 11.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 14.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 15.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 14.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 1.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 15.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 2.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 2.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 1.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 2.2 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 7.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 4.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 3.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 5.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 5.2 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 4.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 2.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 2.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 25.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.2 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 8.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.5 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 7.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.8 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 26.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 3.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 8.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 1.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 6.4 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.1 | 0.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 93.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 0.6 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 3.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 15.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 3.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 1.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 4.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 2.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 5.4 | GO:0099572 | postsynaptic specialization(GO:0099572) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 1.9 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 6.1 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 22.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
5.5 | 22.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
4.9 | 4.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.6 | 13.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
4.6 | 13.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
4.4 | 26.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
4.1 | 12.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.9 | 31.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.8 | 11.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
3.6 | 10.8 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
3.5 | 10.4 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
3.4 | 10.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
3.3 | 26.5 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
3.3 | 13.2 | GO:0045182 | translation regulator activity(GO:0045182) |
3.2 | 12.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
3.1 | 15.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
3.0 | 15.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
3.0 | 8.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.9 | 23.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
2.9 | 8.7 | GO:0035939 | microsatellite binding(GO:0035939) |
2.9 | 8.6 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
2.9 | 11.5 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
2.9 | 20.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.8 | 13.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.7 | 10.7 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
2.7 | 34.8 | GO:0005522 | profilin binding(GO:0005522) |
2.7 | 154.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
2.5 | 14.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.4 | 9.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.4 | 12.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
2.4 | 7.1 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
2.4 | 11.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.3 | 16.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
2.3 | 11.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.3 | 18.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.3 | 13.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
2.3 | 25.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.3 | 11.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.2 | 4.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.1 | 12.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.1 | 32.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
2.0 | 20.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.0 | 4.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.0 | 19.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.0 | 5.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.9 | 7.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.9 | 11.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.9 | 13.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.9 | 69.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.8 | 5.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.8 | 10.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.7 | 1.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.7 | 22.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.7 | 12.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.7 | 10.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.7 | 6.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.7 | 3.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.7 | 18.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
1.7 | 6.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
1.7 | 11.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.6 | 1.6 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
1.6 | 14.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.6 | 6.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
1.6 | 15.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.6 | 6.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.5 | 4.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.5 | 4.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.5 | 12.1 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 10.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.5 | 20.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.5 | 11.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 4.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.5 | 3.0 | GO:0034046 | poly(G) binding(GO:0034046) |
1.5 | 4.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.4 | 10.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.4 | 5.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.4 | 4.3 | GO:0019002 | GMP binding(GO:0019002) |
1.4 | 4.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
1.4 | 4.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.4 | 4.1 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.4 | 4.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.3 | 12.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.3 | 4.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.3 | 5.4 | GO:2001069 | glycogen binding(GO:2001069) |
1.3 | 6.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 3.9 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.3 | 36.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.3 | 7.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.2 | 7.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.2 | 4.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.2 | 1.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.2 | 3.6 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.2 | 5.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.2 | 26.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.2 | 9.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.2 | 9.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.2 | 8.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 9.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.1 | 4.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
1.1 | 9.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 6.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 3.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.1 | 17.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.1 | 6.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.1 | 7.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.1 | 3.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.1 | 7.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.1 | 30.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.1 | 3.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.1 | 4.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.1 | 4.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.1 | 3.3 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.1 | 7.6 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
1.1 | 5.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.1 | 3.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
1.1 | 10.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.0 | 3.1 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
1.0 | 8.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.0 | 14.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.0 | 22.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.0 | 5.0 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 5.0 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.0 | 8.9 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 3.9 | GO:0038132 | neuregulin binding(GO:0038132) |
1.0 | 7.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 3.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.0 | 11.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 2.9 | GO:0071253 | connexin binding(GO:0071253) |
1.0 | 9.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 3.9 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
1.0 | 2.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 15.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.0 | 34.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 29.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.9 | 2.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.9 | 11.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.9 | 2.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.9 | 0.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.9 | 22.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.9 | 25.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.9 | 1.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.9 | 6.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.9 | 11.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.9 | 6.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.9 | 9.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 12.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 6.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 2.7 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.9 | 2.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.9 | 18.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 1.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.9 | 1.7 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.9 | 2.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.9 | 3.5 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.9 | 3.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 9.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.9 | 5.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.9 | 3.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 2.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.9 | 3.4 | GO:0002135 | CTP binding(GO:0002135) |
0.8 | 5.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 1.7 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.8 | 2.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.8 | 3.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 5.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 2.5 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.8 | 2.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.8 | 46.9 | GO:0070888 | E-box binding(GO:0070888) |
0.8 | 4.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.8 | 10.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 14.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 8.7 | GO:0051861 | glycolipid binding(GO:0051861) |
0.8 | 12.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.8 | 0.8 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.8 | 6.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 13.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 3.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.8 | 12.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.8 | 2.3 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.8 | 79.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.8 | 1.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.8 | 2.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 6.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 3.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.7 | 3.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 3.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 2.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.7 | 3.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.7 | 2.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.7 | 4.4 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.7 | 2.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 7.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 4.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.7 | 4.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 9.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.7 | 3.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.7 | 3.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 2.1 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.7 | 18.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.7 | 10.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 4.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.7 | 2.0 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.7 | 2.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.7 | 28.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.7 | 2.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.7 | 6.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.7 | 46.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.7 | 4.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 1.3 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.7 | 8.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 2.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 2.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.7 | 35.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 7.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 30.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 2.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 2.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.6 | 5.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 1.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.6 | 6.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.6 | 4.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.6 | 2.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 1.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.6 | 3.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.6 | 11.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 10.0 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 6.5 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.6 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 3.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 4.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 9.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 3.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 21.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 2.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 2.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 1.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.6 | 4.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 1.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 2.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.6 | 1.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 1.6 | GO:1902271 | lithocholic acid binding(GO:1902121) D3 vitamins binding(GO:1902271) |
0.5 | 2.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 0.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.5 | 2.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.5 | 2.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.5 | 3.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 4.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 2.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.5 | 1.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.5 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.6 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.5 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 2.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 3.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.5 | 4.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 4.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 5.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 51.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 19.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 1.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 12.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 2.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 1.0 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.5 | 1.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.5 | 2.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.5 | 11.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 3.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 1.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 7.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.5 | 5.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 5.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 2.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 5.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.5 | 8.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 1.5 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.5 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 6.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 1.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 7.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 4.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.5 | 1.4 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 2.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 1.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 2.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 3.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 1.9 | GO:0070976 | TIR domain binding(GO:0070976) |
0.5 | 2.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 1.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.5 | 1.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 1.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.5 | 4.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 19.2 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 10.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 8.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 2.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 1.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 5.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 90.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 1.3 | GO:0004335 | galactokinase activity(GO:0004335) |
0.4 | 15.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 3.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 3.0 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.4 | 1.7 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.4 | 3.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 1.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.4 | 11.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 16.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 2.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.4 | 1.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.4 | 1.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.4 | 1.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.4 | 2.3 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.4 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 2.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 4.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 3.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 7.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 11.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.4 | 1.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 4.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 0.4 | GO:0070540 | stearic acid binding(GO:0070540) |
0.4 | 1.4 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.4 | 1.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 1.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 3.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 2.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.4 | 2.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 49.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 6.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 35.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 5.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 15.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 3.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 1.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 8.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 6.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 9.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.6 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.3 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 46.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 1.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 1.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 0.6 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.3 | 14.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 0.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 1.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 7.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 4.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 2.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 4.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 1.1 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.3 | 2.1 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 1.6 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.3 | 1.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 0.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 2.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 2.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 9.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 5.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 2.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.5 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 2.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 18.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 4.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 4.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 5.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 2.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 5.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 2.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 4.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 6.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 5.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.6 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 1.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 3.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.8 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.2 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 2.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.6 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 3.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.2 | GO:0080084 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.2 | 1.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 3.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.9 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 9.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 1.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 22.9 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 2.1 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 4.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 6.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.2 | 27.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.2 | 0.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 0.5 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.2 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 1.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.4 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.1 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 34.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 8.5 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.6 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 2.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 2.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 1.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 1.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 1.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 2.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 1.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 4.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 8.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 1.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.0 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 9.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 3.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 1.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 20.0 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 66.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.3 | 2.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
2.2 | 2.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
2.1 | 19.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.6 | 95.3 | PID PLK1 PATHWAY | PLK1 signaling events |
1.5 | 38.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.5 | 10.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.5 | 16.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.3 | 47.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.3 | 6.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.3 | 54.3 | PID AURORA B PATHWAY | Aurora B signaling |
1.2 | 24.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.2 | 49.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.2 | 13.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.2 | 60.5 | PID IGF1 PATHWAY | IGF1 pathway |
1.2 | 42.8 | PID ATR PATHWAY | ATR signaling pathway |
1.1 | 50.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.0 | 32.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.0 | 2.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.0 | 45.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.0 | 38.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.9 | 25.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.9 | 54.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 16.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 8.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.8 | 26.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.8 | 4.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.8 | 13.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.7 | 60.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 39.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 18.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.7 | 27.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 9.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.7 | 7.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 40.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 12.6 | PID ATM PATHWAY | ATM pathway |
0.7 | 19.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.7 | 18.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 5.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 3.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 40.4 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 41.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 19.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 5.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 4.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 21.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 4.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 1.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 25.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.5 | 11.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 31.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.5 | 33.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 28.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 12.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 18.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 9.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 1.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 9.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 3.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 9.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 10.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 4.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 18.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 3.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 7.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 2.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 1.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 21.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 9.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 6.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 2.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 10.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 2.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 3.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 2.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 1.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 5.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 9.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 3.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 11.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 36.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 9.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 8.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 7.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 12.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 6.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 103.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
3.2 | 67.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.9 | 5.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.9 | 22.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.9 | 59.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.5 | 27.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.2 | 28.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.1 | 29.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
2.0 | 2.0 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
1.8 | 1.8 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
1.6 | 28.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.5 | 10.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.5 | 40.9 | REACTOME KINESINS | Genes involved in Kinesins |
1.4 | 17.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.4 | 25.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.4 | 27.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.4 | 60.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.3 | 51.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.3 | 32.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.3 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.2 | 14.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.2 | 11.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 24.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.1 | 18.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 40.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 2.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.0 | 3.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.0 | 30.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.9 | 25.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.9 | 30.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.9 | 18.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.9 | 6.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.9 | 22.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 19.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 63.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 9.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.9 | 41.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 3.3 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.8 | 32.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 29.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.7 | 38.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 5.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 27.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 16.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.7 | 12.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.7 | 26.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.7 | 1.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.7 | 16.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 8.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 8.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 3.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.6 | 0.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 3.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 4.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 1.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 4.7 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.6 | 52.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 4.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 16.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 6.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 12.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 33.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 3.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 16.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 19.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 10.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 7.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 6.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 2.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.5 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 12.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 9.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 5.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 8.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 11.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 32.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 2.7 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.4 | 22.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 7.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 2.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 6.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 7.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 7.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 26.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 20.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 12.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 2.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 2.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.4 | 6.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 4.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 3.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 8.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 9.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 17.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 4.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 4.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 40.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 7.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 5.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 1.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 2.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 6.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 4.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 4.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 4.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 2.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 7.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 4.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 23.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 1.2 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 1.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 5.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 1.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 21.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 11.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 5.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 2.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 31.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 2.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 14.7 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.2 | 5.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 10.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.9 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 4.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 2.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.2 | 2.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 13.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 6.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 2.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 3.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 8.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.4 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 1.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 9.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |